Cancer biomarkers help to detect cancer at an early stage and help monitor its progression or response to treatment. They play a key role in personalizing cancer treatment plans based on a patient's genetic profile and expected response to various drug therapies. Rising prevalence of cancer worldwide coupled with high cost of treatment is driving increased adoption of personalized medicine approaches. This helps achieve higher survival rates and better therapeutic outcomes in a cost effective manner.
Market key trends:
Advancements in proteomics and bioinformatics are enabling development of novel cancer biomarker panels that can detect cancer early with high sensitivity and specificity. Multi-analyte biomarker tests that can predict the risk of cancer recurrence as well as response to targeted therapies from a simple blood draw are gaining popularity. Researchers are also exploring exosome analysis as a potential non-invasive liquid biopsy technique for detection of cancer biomarkers. Such innovations are expected to make cancer screening and management more convenient for both patients and healthcare providers.
Segment Analysis
The cancer biomarkers market is segmented by disease indication into lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, blood cancer, kidney cancer, ovarian cancer, and others. The lung cancer segment dominated other segments in 2020 due to high incidence rates of lung cancer globally. The lung cancer segment is also expected to maintain its dominating position during the forecast period.
Key Takeaways
The Global Cancer Biomarkers Market Growth is expected to witness high.
Regional analysis related to the Asia Pacific region is expected to be the fastest growing region due to large patient population, increasing healthcare expenditure, growing awareness about early detection of cancer.
Key players operating in the Cancer Biomarkers market are Schlumberger Limited, Rockwell Automation Inc., SIS-TECH Solutions LP, Emerson Electric Company, HIMA Paul Hildebrandt GmbH, Honeywell International Inc., Siemens AG, Yokogawa Electric Corporation, Schneider Electric SE, and ABB Ltd.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/cancer-biomarkers-market-share-and-demand-analysis-2/
Explore more trending article related this topic -
https://www.insightprobing.com/biopharma-buffer-market-share-and-demand-analysis/
Comments
0 comment